N-(2,4-dinitrophenyl)-N-methylglycine, 98%, 250mg

Ethyl 4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxylate, 95+%, 250mg

Furo[2,3-c]pyridin-3(2H)-one hydrochloride, 95.0%, 1g

H-Lys-OH.2HCl, 95%, 25g

(4-(3-Chloropropoxy)phenyl)boronic acid, 95+%, 100mg

Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate, 95.0%, 10g

(3a'R,4'S,6'R,7'R,7a'S)-4'-((R)-1,4-Dioxaspiro[4.5]decan-2-yl)tetrahydro-4'H-spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-c]pyran]-6',7'-diol, 98%, 1g

[(2,4-dimethylphenyl)methyl](propan-2-yl)amine hydrochloride, 95.0%, 2g

Sodium 2-amino-2-benzamidoacetate, 95.0%, 25g

Boc-L-Leucine hydrate, 95.0%, 100g

Methyl 3-chloropicolinate, 95.0%, 25g

D-m-Tyrosine, 95.0%, 25g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, calibrada de fábrica, 0,001 g, 320 g, BCE323i-1CEU (W)